GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: Kepivance® | keratinocyte growth factor
                                 palifermin is an approved drug (FDA (2004), EMA (2005)) Compound class: 
                                                            Peptide
                                 
                                    
                                        Comment: Palfermin is a modified truncated form of human keratinocyte growth factor produced by recombinant DNA technology.
                                    
                                 | 
| Classification  | |
| Compound class | Peptide | 
| Approved drug? | Yes. EU EMA (2005) | US FDA (2004) | 
| International Nonproprietary Names  | |
| INN number | INN | 
| 8186 | palifermin | 
| Synonyms  | 
| Kepivance® | keratinocyte growth factor | 
| Database Links  | |
| CAS Registry No. | 162394-19-6 (source: Scifinder) | 
| ChEMBL Ligand | CHEMBL1201821 | 
| DrugBank Ligand | DB00039 | 
| GtoPdb PubChem SID | 178103536 | 
| PubChem SID | 135252604 | 
| Search PubMed clinical trials | palifermin | 
| Search PubMed titles | palifermin | 
| Search PubMed titles/abstracts | palifermin | 
| Wikipedia | Palifermin |